The role of acquired host immunity in periodontal diseases.
acquired immunity
antibodies
cellular immunity
humoral immunity
lymphocytes
Journal
Periodontology 2000
ISSN: 1600-0757
Titre abrégé: Periodontol 2000
Pays: Denmark
ID NLM: 9313276
Informations de publication
Date de publication:
20 Apr 2024
20 Apr 2024
Historique:
revised:
06
02
2024
received:
14
12
2022
accepted:
04
03
2024
medline:
20
4
2024
pubmed:
20
4
2024
entrez:
20
4
2024
Statut:
aheadofprint
Résumé
The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease. While the contribution of European authors is the focus, global literature is included in this descriptive narrative for contextual clarity, albeit many with European co-authors. The topic is relatively intense and is thus broken down into sections outlined below, tackled as descriptive narratives to enhance understanding. Any attempt at a systematic or scoping review was quickly abandoned given the descriptive nature and marked variation of approach in almost all publications. Even the most uniform area of this acquired periodontal immunology literature, antibody responses to putative pathogens in periodontal diseases, falls short of common structures and common primary outcome variables one would need and expect in clinical studies, where randomized controlled clinical trials (RCTs) abound. Addressing 'the host's role' in immunity immediately requires a discussion of host susceptibility, which necessitates consideration of genetic studies (covered elsewhere in the volume and superficially covered here).
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd.
Références
Papapanou PN, Wennstrom JL, Grondhal K. Periodontal status in relation to age and tooth type. A cross‐sectional radiographic study. J Clin Periodontol. 1988;15:469‐478.
Petersen PE, Bourgeois D, Ogawa H, Estupinan‐Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull WHO. 2005;83:661‐669.
Jenkins WMM, Kinane DF. The ‘high risk’ group in periodontitis. Br Dent J. 1989;167:168–171.
de Coo A, Cruz R, Quintela I, et al. 2013‐wide association study of stage III/IV grade C periodontitis (former aggressive periodontitis) in a Spanish population. J Clin Periodontol. 2021;48:896‐906.
Divaris K, Monda KL, North KE, et al. Exploring the genetic basis of chronic periodontitis: a genome‐wide association study. Hum Mol Genet. 2013;22:2312‐2324.
Nibali L, Bayliss‐Chapman J, Almofareh SA, Zhou Y, Divaris K, Vieira AR. What is the heritability of periodontitis? A systematic review. J Dent Res. 2019;98:632‐641.
Tegelberg P, Leppilahti JM, Ylöstalo A, et al. Genome‐wide association study of periodontal pocketing in Finnish adults. BMC Oral Health. 2021;21(1):611.
The Welcome Trust Case Control Consortium. Genome‐wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. 2007 Multicenter Study. R, Report No.: 1476–4687 (Electronic).
Platt D, Crosby RG, Dalbow MH. Evidence for the presence of immunoglobulins and antibodies in inflamed periodontal tissues. J Periodontol. 1970;41:215‐222.
Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol. 1984;11:21‐32.
Lu H, Califano IV, Schenkein HA, Tew JG. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomifans serotype b. Infect Immun. 1993;61:2400‐2407.
Tangada SD, Califano JV, Nakashima K, et al. The effect of smoking on serum IgG2 reactive with Actinobacillus actinomycetemcomitans in early‐onset periodontitis patients. J Periodontol. 1997;68:842‐850.
Mooney J, Adonogianaki E, Kinane DF. Relative avidity of serum antibodies to putative periodontopathogens in periodontal disease. J Periodontal Res. 1993;28:444‐450.
Kinane DF, Takahashi K, Mooney J. Crevicular fluid and serum IgG subclasses and corresponding mRNA expressing plasma cells in periodontitis lesions. J Periodontal Res. 1997;32:176–178.
Cutler CW, Teng YT. Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists. Periodontol. 2007;45(35–50):35‐50.
Jotwani R, Palucka AK, Al‐Quotub M, et al. Mature dendritic cells infiltrate the T cell‐rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol. 2001;167:4693‐4700.
Seguier S, Godeau G, Brousse N. Immunohistological and morphometric analysis of intra‐epithelial lymphocytes and Langerhans cells in healthy and diseased human gingival tissues. Arch Oral Biol. 2000;45:441‐452.
Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol. 2002;7:62‐71.
Kinane DF, Preshaw PM, Loos BG. Host‐response: understanding the cellular and molecular mechanisms of host‐microbial interactions ‐ consensus of the seventh European workshop on periodontology. J Clin Periodontol. 2011;38(44–48):44‐48.
Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(60–84):60‐84.
Kinane DF, Goudie RB, Karim SN, Garioch JJ, Moughal NA, Al BA. Heterogeneity and selective localisation of T cell clones in human skin and gingival mucosa. J Periodontal Res. 1993;28:497‐499.
Kinane DF, Adonogianaki E, Moughal N, Mooney J, Thornhill M. Immunocytochemical characterisation of cellular infiltrate, related endothelial changes and determination of GCF acute phase proteins during human experimental gingivitis. J Periodontal Res. 1991;26:286‐288.
Kinane DF, Mooney J, MacFarlane TW, McDonald M. Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: correlation with clinical indices. Oral Microbiol Immunol. 1993;8:65‐68.
Kinane DF, Mooney J, Ebersole J. Humoral immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease. Periodontol 2000. 1999;20:289‐340.
Mooney J, Kinane DF. Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis. Oral Microbiol Immunol. 1994;9:321‐326.
Naito Y, Okuda K, Takazoe I. Detection of specific antibody in adult human periodontitis sera to surface antigens of Bacteroides gingivalis. Infect Immun. 1987;55:832‐834.
Aukhil I, Lopatin DE, Syed SA, Morrison EC, Kowalski CJ. The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms. J Clin Periodontol. 1988;15:544‐550.
Mooney J, Adonogianaki E, Riggio M, Takahashi K, Haerian A, Kinane DF. Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis. Infect Immun. 1995;63:3411‐3416.
Modeer T, Dahllof G, Axio E, Sundqvist KG. Subpopulations of lymphocytes in connective tissue from adolescents with periodontal disease. Acta Odontol Scand. 1990;48:153‐159.
Berglundh T, Liljenberg B, Tarkowski A, Lindhe J. Local and systemic TCR V gene expression in advanced periodontal disease. J Clin Periodontol. 1998;25:125‐133.
Berglundh T, Krok L, Liljenberg B, Westfelt E, Serino G, Lindhe J. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodontol. 1998;5:354‐362.
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin‐8 and RANTES chemokines in adult periodontitis. J Periodontal Res. 2001;36:194‐203.
Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J Clin Periodontol. 1999;26:183‐189.
Zappa U. Histology of the periodontal lesion: implications for diagnosis. Periodontol 2000. 1995;7:22–38.
MacLeod MK, Kappler JW, Marrack P. Memory CD4 T cells: generation, reactivation and re‐assignment. Immunology. 2010;130:10‐15.
Campbell L, Millhouse E, Malcolm J, Culshaw S. T cells, teeth and tissue destruction‐what do T cells do in periodontal disease? Mol Oral Microbiol. 2016;31:445‐456.
Cardoso C, Garlet G, Moreira A, Júnior W, Rossi M, Silva J. Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis. J Leukoc Biol. 2008;84:311‐318.
Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009;24:1‐6.
Cheng WC, Hughes FJ, Taams LS. The presence, function and regulation of IL‐17 and Th17 cells in periodontitis. J Clin Periodontol. 2014;41:541‐549.
Ernst CW, Lee JE, Nakanishi T, et al. Diminished forkhead box P3/CD25 double‐positive T regulatory cells are associated with the increased nuclear factor‐kappaB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol. 2007;148:271‐280.
Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re‐thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL‐17. J Dent Res. 2008;87:817‐828.
Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17‐producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123‐1132.
Jenkins MK, Moon JJ. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol. 2012;188:4135‐4140.
Tubo NJ, Pagan AJ, Taylor JJ, et al. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell. 2013;153:785‐796.
Mason D. A very high level of crossreactivity is an essential feature of the T‐cell receptor. Immunol Today. 1998;19:395‐404.
Stein JM, Machulla HK, Smeets R, Lampert F, Reichert S. Human leukocyte antigen polymorphism in chronic and aggressive periodontitis among Caucasians: a meta‐analysis. J Clin Periodontol. 2008;35:183‐192.
Vuchkovska A, Glanville DG, Scurti GM, et al. Siglec‐5 is an inhibitory immune checkpoint molecule for human T cells. Immunology. 2022;166:238‐248.
Zoheir N, Kurushima Y, Lin GH, Nibali L. Periodontal infectogenomics: a systematic review update of associations between host genetic variants and subgingival microbial detection. Clin Oral Investig. 2022;26:2209‐2221.
Divaris K, Haworth S, Shaffer JR, et al. Phenotype harmonization in the GLIDE2 Oral Health Genomics Consortium. J Dent Res. 2022;101:1408–1416.
Nibali L, Parkar M, Brett P, Knight J, Tonetti MS, Griffiths GS. NADPH oxidase (CYBA) and FcgammaR polymorphisms as risk factors for aggressive periodontitis: a case‐control association study. J Clin Periodontol. 2006;33:529‐539.
Nibali L, O'Dea M, Bouma G, et al. Genetic variants associated with neutrophil function in aggressive periodontitis and healthy controls. J Periodontol. 2010;81:527‐534.
Irwandi RA, Kuswandani SO, Harden S, Marletta D, D'Aiuto F. Circulating inflammatory cell profiling and periodontitis: a systematic review and meta‐analysis. J Leukoc biol. 111:1069‐1096. Ismail AI, Burt BA, Eklund SA (1983). Epidemiologic patterns of smoking and periodontal disease in the United States. J Am Dent Assoc. 2022;106:617‐621.
Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551‐2556.
Berglundh T, Liljenberg B, Lindhe J. Some effects of periodontal therapy on local and systemic immunological parameters. Jo of Clinical Periodontology. 1999;2:91‐98.
Rajendran M, Looney S, Singh N, et al. (2019) systemic antibiotic therapy reduces circulating inflammatory dendritic cells and Treg‐Th17 plasticity in periodontitis. J Immunol. 2019;202:2690‐2699.
Liljenberg B, Lindhe J, Berglundh T, Dahlen G, Jonsson R. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. J Clin Periodontol. 1994;21:720‐727.
Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol. 2005;32:87‐107.
Berglundh T, Liljenberg B, Lindhe J. Some cytokine profiles of T‐helper cells in lesions of advanced periodontitis. J Clin Periodontol. 2002;29:706‐709.
Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of Interleukin‐17 in the immunopathology of periodontal disease. J Clin Periodontol. 2005;32:369‐374.
Dutzan N, Vernal R, Vaque JP, et al. Interleukin‐21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. J Periodontol. 2012;83:948‐954.
Langrish CL, Chen Y, Blumenschein WM, et al. IL‐23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233‐240.
Williams TC, Jackson DJ, Maltby S, et al. Rhinovirus‐induced CCL17 and CCL22 in asthma exacerbations and differential regulation by STAT6. Am J Respir Cell Mol Biol. 2021;64:344‐356.
Ryder MI, Nittayananta W, Coogan M, Greenspan D, Greenspan JS. Periodontal Disease in HIV/AIDS. Periodontol. 2012;2000(60):78‐97.
Wood NH, Blignaut E, Lemmer J, Meyerov R, Feller L. Necrotizing periodontal diseases in a semirural district of South Africa. AIDS res treat. 2011;2011:638584.
Ho S, Clipstone N, Timmermann L, et al. The mechanism of action of cyclosporin a and FK506. Clin Immunol Immnopathol. 1996;80(3 Pt 2):5.
Manhart SS, Reinhardt RA, Payne JB, et al. Gingival cell IL‐2 and IL‐4 in early‐onset periodontitis. J Periodontol. 1994;65:807‐813.
Pejcic A, Djordjevic V, Kojovic D, et al. Effect of periodontal treatment in renal transplant recipients. Med Princ Pract. 2014;23:149‐153.
Schmalz G, Wendorff H, Berisha L, et al. Association between the time after transplantation and different immunosuppressive medications with dental and periodontal treatment need in patients after solid organ transplantation. Transpl Infect Dis. 2018;20:e12832.
Silva LM, Brenchley L, Moutsopoulos NM. Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis. Immunol Rev. 2019;287:226‐235.
Silva LM, Doyle AD, Greenwell‐Wild T, et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science. 2021;74(6575):eabl5450.
da Silva Peralta F, Pallos D, Silva Queiroz C, Ricardo LH. Previous exposure to Cyclosporine A and periodontal breakdown in rats. Arch Oral Biol. 2015;60:566–573.
Moura Penteado LA, Lucena GM, Brandão Peixoto MO, Barbosa TC, de Souza Leitão Arruda AC, Cimões R. Evaluation of the effect of tacrolimus on periodontitis induced in rats. Arch Oral Biol. 2017;80:89–94.
Baker P, Evans R, Roopenian D. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol. 1994;39:1035‐1040.
Baker PJ, Howe L, Garneau J, Roopenian DC. T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2002;34:45‐50.
Park JC, Kim BK, Jung IH, Choi E, Kim CS. Alveolar Bone Resorption Induced by CD4+CD45RB High‐Density T‐Cell Transfer in Immunocompromised Mice. J Periodontol. 2014;85:e339‐e347.
Baker P, Dixon M, Evans R, Dufour L, Johnson E, Roopenian D. CD4(+) T cells and the proinflammatory cytokines g interferon and interleukin‐6 contribute to alveolar bone loss in mice. Infect Immun. 1999;67:2804‐2809.
Garlet GP, Cardoso CR, Campanelli AP, et al. The essential role of IFN‐g in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect. 2008;10:489‐496.
Malcolm J, Awang RA, Oliver‐Bell J, et al. IL‐33 exacerbates periodontal disease through induction of RANKL. J Dent Res. 2015;94:968‐975.
Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223‐246.
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.PG – 2348‐57. J Immunol. 1986;136:2348‐2357.
Yu J, Ruddy M, Wong G, et al. An essential role for IL‐17 in preventing pathogen‐initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL‐17 receptor‐dependent signals. Blood. 2007;109:3794‐3802.
Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del‐1 inhibits IL‐17‐mediated inflammatory bone loss. Nat Immunol. 2012;13:465‐473.
Bittner‐Eddy PD, Fischer LA, Costalonga M. Transient expression of IL‐17A in Foxp3 fate‐tracked cells in Porphyromonas gingivalis‐mediated Oral Dysbiosis. Front Immunol. 2020;11:677.
Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL‐1, and TNF are regulated by IL‐17 in periodontitis. J Dent Res. 2007;86:347‐351.
Ikeuchi T, Moutsopoulos NM. Osteoimmunology in periodontitis; a paradigm for Th17/IL‐17 inflammatory bone loss. Bone. 2022;163:116500.
Awang RA, Lappin DF, MacPherson A, et al. Clinical associations between IL‐17 family cytokines and periodontitis and potential differential roles for IL‐17A and IL‐17E in periodontal immunity. Inflamm Res. 2014;63:1001‐1012.
Mitani A, Niedbala W, Fujimura T, et al. Increased expression of interleukin (IL)‐35 and IL‐17, but not IL‐27, in gingival tissues with chronic periodontitis. J Periodontol. 2015;86:301‐309.
Fort MM, Cheung J, Yen D, et al. IL‐25 induces IL‐4, IL‐5, and IL‐13 and Th2‐associated pathologies in vivo. Immunity. 2001;15(6):985‐995.
Honda T, Aoki Y, Takahashi N, et al. Elevated expression of IL‐17 and IL‐12 genes in chronic inflammatory periodontal disease. Clin Chim Acta. 2008;395:137‐141.
Garlet GP, Cardoso CR, Mariano FS, et al. Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol. 2010;37:591‐600.
Taubman MA, Kawai T. Involvement of T‐lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med. 2001;12:125‐135.
Glowacki AJ, Yoshizawa S, Jhunjhunwala S, et al. Prevention of inflammation‐mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci USA. 2013;110:18525‐18530.
Alvarez C, Suliman S, Almarhoumi R, et al. Regulatory T cell phenotype and anti‐osteoclastogenic function in experimental periodontitis. Sci Rep. 2020;10:19018.
Barel O, Aizenbud Y, Tabib Y, et al. γδ T cells differentially regulate bone loss in periodontitis models. J Dent Res. 2022;101:428‐436.
Krishnan S, Prise IE, Wemyss K, et al. Amphiregulin‐producing γδ T cells are vital for safeguarding oral barrier immune homeostasis. Proc Natl Acad Sci USA. 2018;115:10738‐10743.
Snir O, Rieck M, Gebe JA, et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA‐DRB1*0401‐positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 2011;63:2873‐2883.
Bittner‐Eddy PD, Fischer LA, Costalonga M. Identification of gingipain‐specific I‐A(b) ‐restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice. Mol Oral Microbiol. 2013;28:452‐466.
Yan Y, Chen R, Wang X, et al. CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention. Front Cell Dev Biol. 2019;7:212.
Kitamoto S, Nagao‐Kitamoto H, Jiao Y, et al. The Intermucosal connection between the mouth and gut in commensal Pathobiont‐driven colitis. Cell. 2020;182:447‐462.
Geatch DR, Ross DA, Heasman PA, Taylor JJ. Expression of T‐cell receptor Vbeta2, 6 and 8 gene families in chronic adult periodontal disease. Eur J Oral Sci. 1997;105:397‐404.
Nakajima T, Yamazaki K, Hara K. Biased T cell receptor V gene usage in page and Schroeder (1976),page, R.C. And H.E. Schroeder. 1976. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Investig. 1996;34:235‐249.
Yamazaki K, Nakajima T, Kubota Y, Gemmell E, Seymour GJ, Hara K. Cytokine messenger RNA expression in chronic inflammatory periodontal disease. Oral Microbiol Immunol. 1997;12:281‐287.
Han A, Glanville J, Hansmann L, Davis MM. Linking T‐cell receptor sequence to functional phenotype at the single‐cell level. Nat Biotechnol. 2014;32:684‐692.
Karimzadeh K, Morrison J, Zadeh HH. Comparison of gingival and peripheral blood T cells among patients with periodontitis suggests skewing of the gingival T cell antigen receptor V beta repertoire. J Periodontal Res. 1999;34:445‐456.
Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T‐lymphocytes from gingival tissues with pathological pocketing. J Dent Res. 2000;79:1548‐1555.
Vernal R, Dutzan N, Hernandez M, et al. High expression levels of receptor activator of nuclear factor‐kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes. J Periodontol. 2006;77:1772‐1780.
Belibasakis GN, Bostanci N. The RANKL‐OPG system in clinical periodontology. J Clin Periodontol. 2012;39:239‐248.
Bostanci N, Ilgenli T, Emingil G, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol. 2007;34:370‐376.
Gemmell E, Grieco DA, Cullinan MP, Westerman B, Seymour GJ. Antigen‐specific T‐cell receptor V beta expression in Porphyromonas gingivalis‐specific T‐cell lines. Oral Microbiol Immunol. 1998;13(6):355‐361.
Gumus P, Nizam N, Lappin DF, Buduneli N. Saliva and serum levels of B‐cell activating factors and tumor necrosis factor‐alpha in patients with periodontitis. J Periodontol. 2014;85:270‐280.
Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodontal Res. 1993;28:478‐486.
Seymour GJ, Gemmell E, Kjeldsen M, et al. Cellular immunity and hypersensitivity as components of periodontal destruction. Oral Dis. 1996;2:96‐101.
Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol. 1996;103(3):422‐428.
Yamamoto M, Fujihashi K, Hiroi T, McGhee JR, Van Dyke TE, Kiyono H. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammation. J Periodontal Res. 1997;32:115‐119.
Yamazaki K, Nakajima T, Gemmell E, Polak B, Seymour GJ, Hara K. IL‐4 and IL‐6 producing cells in human periodontal disease tissue. J Oral Pathol Med. 1994;23:347‐353.
Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J Periodontol. 1996;67:515–522.
Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, Behfarnia P, Shahabuei M, Rafiee L. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res. 2012;47:525‐531.
Allam JP, Duan Y, Heinemann F, et al. IL‐23‐producing CD68(+) macrophage‐like cells predominate within an IL‐17‐polarized infiltrate in chronic periodontitis lesions. J Clin Periodontol. 2011;38:879‐886.
Sugawara M, Yamashita K, Yoshie H, Hara K. Detection of, and anti‐collagen antibody produced by, CD5‐positive B cells in inflamed gingival tissues. J Periodontal Res. 1992;27:489‐498.
Zouali M. The emerging roles of B cells as partners and targets in periodontitis. Autoimmunity. 2017;50:61‐70.
Koulouri O, Lappin DF, Radvar M, Kinane DF. Cell division, synthetic capacity and apoptosis in periodontal lesions analysed by in situ hybridisation and immunohistochemistry. J Clin Periodontol. 1999;26:552‐559.
Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976;34:235–249.
Kinane DF. Causation and pathogenesis of periodontal disease. Periodontology. 2000;2001(25):8–20.
Lindhe J, Hamp S, Loe H. Experimental periodontitis in the beagle dog. J Periodontal Res. 1973;8:1‐10.
Wittwer JW, Dickler EH, Toto PD. Comparative frequencies of plasma cells and lymphocytes in gingivitis. J Periodontol. 1969;40:274‐275.
Mackler BF, Frostad KB, Robertson PB, Levy BM. Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. J Periodontal Res. 1977;12:37‐45.
Lappin DF, MacLeod CP, Kerr A, Mitchell T, Kinane DF. Anti‐inflammatory cytokine IL‐10 and T cell cytokine profile in periodontitis granulation tissue. Clin Exp Immunol. 2001;123:294‐300.
Han X, Lin X, Seliger AR, Eastcott J, Kawai T, Taubman MA. Expression of receptor activator of nuclear factor‐kappaB ligand by B cells in response to oral bacteria. Oral Microbiol Immunol. 2009;24:190‐196.
Han X, Lin X, Yu X, et al. Porphyromonas gingivalis infection‐associated periodontal bone resorption is dependent on receptor activator of NF‐kappaB ligand. Infect Immun. 2013;81:1502‐1509.
Kawai T, Matsuyama T, Hosokawa Y, et al. B and T lymphocytes are the primary sources of RANKL in the bone Resorptive lesion of periodontal disease. Am J Pathol. 2006;169:987‐998.
Brandtzaeg P. Local factors of resistance in the gingival area. J Periodontal Res. 1966;1:19‐42.
Genco RJ, Mashimo PA, Krygier G, Ellison SA. Antibody‐mediated effects on the periodontium. J Periodontol. 1974;45:330‐337.
Schneider TF, Toto PD, Gargiulo AW, Pollock RJ. Specific bacterial antibodies in the inflamed human gingiva. Periodontics. 1966;4:53‐57.
Mayer EP, Chen WY, Dray S, Teodorescu M. The identification of six mouse lymphocyte subpopulations by their natural binding of bacteria. J Immunol. 1978;120:167–173.
Schonfeld SE, Kagan JM. Specificity of gingival plasma cells for bacterial somatic antigens. J Periodontal Res. 1982;17:60‐69.
Schonfeld SE, Kagan JM. Determination of the specificity of plasma cells for bacterial antigens in situ. Infect Immun. 1980;27:947‐952.
Moore WE, Moore LH, Ranney RR, Smibert RM, Burmeister JA, Schenkein HA. The microflora of periodontal sites showing active destructive progression. J Clin Periodontol. 1991;18:729‐739.
Mouton C, Hammond PG, Slots J, Genco RJ. Serum antibodies to oral Bacteroides asaccharolyticus, Bacteroides gingivalis: relationship to age and periodontal disease. Infect Immun. 1981;31:182‐192.
Slots J, Listgarten MA. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol. 1988;15:85‐93.
van Winkelhoff AJ, van Steenbergen TJ, de Graaff J. The role of black‐pigmented Bacteroides in human oral infections. J Clin Periodontol. 1988;15:145‐155.